Article Information
History
- August 10, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sergei Krasny1,*,
- Yauheni Baranau2,*,
- Sergey Polyakov1,
- Ekaterina Zharkova1,
- Olga Streltsova2,
- Aliona Filimonava2,
- Volha Siarheyeva1,
- Sviatlana Kazlouskaya1,
- Anton Khorau1,
- Vladimir Gabai3 and
- Alexander Shneider3,+
- 1N.N. Alexandrov National Cancer Centre of Belarus, Minsk, Belarus
- 2Minsk City Clinical Oncologic Centre, Minsk, Belarus
- 3CureLab Oncology, Inc., Boston, MA, USA
- ↵+corresponding author: Alexander Shneider, CureLab Oncology, 177 Huntingon Ave 17Fl BOSTON MA 02115-3156, ASHNEIDER{at}CURELAB.COM
↵* equal contribution